Physiology of vitreous surgery

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 2, 2009, Pages 147-163

  Stefánsson, Einar ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

Author keywords

Convection currents; Diffusion; Edema; Fick's law; Laser treatment; Macular edema; Newton's third law; Oxygen; Silicone oil; Starling's law; Steroids; Stokes Einstein equation; Vascular endothelial growth factor; Viscosity; Vitrectomy; Vitreoretinal traction; Water

Indexed keywords

BEVACIZUMAB; CORTICOSTEROID; CYTOKINE; OXYGEN; PLASMA PROTEIN; SILICONE OIL; STEROID; TRIAMCINOLONE; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

ARTERIAL PRESSURE; BLOOD VESSEL PERMEABILITY; CATARACT; CYTOKINE PRODUCTION; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; GLAUCOMA; HEMODYNAMICS; HUMAN; HYDROSTATIC PRESSURE; IRIS DISEASE; LASER COAGULATION; LIQUEFACTION; MICROCIRCULATION; NONHUMAN; ONCOTIC PRESSURE; OXIDATIVE STRESS; OXYGEN THERAPY; OXYGEN TRANSPORT; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN TRANSPORT; RETINA ISCHEMIA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA VEIN OCCLUSION; REVIEW; RISK BENEFIT ANALYSIS; RISK REDUCTION; VITRECTOMY; VITREORETINOPATHY; VITREOUS BODY; VITREOUS BODY DETACHMENT; VITREOUS DISEASE;

HUMANS; MODELS, BIOLOGICAL; POSTOPERATIVE COMPLICATIONS; VITRECTOMY; VITREOUS BODY; VITREOUS DETACHMENT;

EID: 57949108546     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0980-7     Document Type: Review

References (159)

1. Schulze S, Hoerle S, Mennel S, Kroll P (2008) Vitreomacular traction and exudative age-related macular degeneration. Acta Ophthalmol 86:470-481
2. Dodo T, Okuzawa Y, Baba N (1969) Trans-pupillary resection of vitreous body opacity. Ganka 11(1):38-44
3. Kasner D, Miller GR, Taylor WH, Sever RJ, Norton W (1968) Surgical treatment of amyloidosis of the vitreous. Trans Am Acad Ophthalmol Otolaryngol 72(3):410-418
4. Kloti R (1975) Pars plana vitrectomy with the vitreous stripper. Mod Probl Ophthalmol 15:246-252
5. Kloti R (1973) Vitrectomy. I. A new instrument for posterior vitrectomy. Albrecht Von Graefes Arch Klin Exp Ophthalmol 187(2):161-170, doi: 10.1007/BF00411214
6. Machemer R (1976) Pars plana vitrectomy. Summary. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 81(3 Pt 1):431
7. Machemer R, Buettner H, Norton EW, Parel JM (1971) Vitrectomy: A pars plana approach. Trans Am Acad Ophthalmol Otolaryngol 75(4):813-820
8. Stefansson E, Loftsson T (2006) The Stokes-Einstein equation and the physiological effects of vitreous surgery. Acta Ophthalmol Scand 84(6):718-719, doi: 10.1111/j.1600-0420.2006.00778.x
9. Boruchoff SA, Woodin AM (1956) Viscosity and composition of solutions derived from rabbit vitreous humour. Br J Ophthalmol 40(2):113-118, doi: 10.1136/bjo.40.2.113
10. Madinaveitia J, Quibell TH (1941) Diffusing factors: The effect of salts on the action of testicular extracts on the viscosity of vitreous humour preparations. Biochem J 35(4):456-460
11. Madinaveitia J, Quibell TH (1940) Studies on diffusing factors: The action of testicular extracts on the viscosity of vitreous humour preparations. Biochem J 34(4):625-631
12. Madinaveitia J, Quibell TH (1941) Studies on diffusing factors: The reduction of the viscosity of vitreous humour preparations by ascorbic acid and some diazo compounds. Biochem J 35(4):453-455
13. Lee B, Litt M, Buchsbaum G (1992) Rheology of the vitreous body. Part I: Viscoelasticity of human vitreous. Biorheology 29(5-6):521-533
14. Gisladottir S, Loftsson T, Stefansson E (2007) Diffusion in the vitreous cavity is related to the viscosity of the medium according to the Stokes Einstein equation. ARVO annual meeting, Fort Lauderdale, Florida, May 6-10 2007, Presentation Number: (5783/B320).
15. Sebag J, Ansari RR, Suh KI (2007) Pharmacologic vitreolysis with microplasmin increases vitreous diffusion coefficients. Graefes Arch Clin Exp Ophthalmol 245(4):576-580, doi: 10.1007/s00417-006-0394-3
16. Soman N, Banerjee R (2003) Artificial vitreous replacements. Biomed Mater Eng 13(1):59-74
17. Stefansson E, Landers MB 3rd, Wolbarsht ML (1981) Increased retinal oxygen supply following pan-retinal photocoagulation and vitrectomy and lensectomy. Trans Am Ophthalmol Soc 79:307-334
18. Stefansson E, Landers MB 3rd, Wolbarsht ML (1982) Vitrectomy, lensectomy, and ocular oxygenation. Retina 2(3):159-166, doi: 10.1097/ 00006982-198200230-00006
19. de Juan E Jr, Hardy M, Hatchell DL, Hatchell MC (1986) The effect of intraocular silicone oil on anterior chamber oxygen pressure in cats. Arch Ophthalmol 104(7):1063-1064
20. Blair NP (2000) Ocular oxygen consumption during vitreoperfusion in the cat. Trans Am Ophthalmol Soc 98:305-329
21. Blair NP, Baker DS, Rhode JP, Solomon M (1989) Vitreoperfusion. A new approach to ocular ischemia. Arch Ophthalmol 107(3):417-423
22. Maeda N, Tano Y (1996) Intraocular oxygen tension in eyes with proliferative diabetic retinopathy with and without vitreous. Graefes Arch Clin Exp Ophthalmol 234(Suppl 1):S66-S69, doi: 10.1007/BF02343050
23. Holekamp NM, Shui YB, Beebe DC (2005) Vitrectomy surgery increases oxygen exposure to the lens: A possible mechanism for nuclear cataract formation. Am J Ophthalmol 139(2):302-310, doi: 10.1016/j.ajo.2004.09.046
24. Shui YB, Fu JJ, Garcia C, Dattilo LK, Rajagopal R, McMillan S et al (2006) Oxygen distribution in the rabbit eye and oxygen consumption by the lens. Invest Ophthalmol Vis Sci 47(4):1571-1580, doi: 10.1167/ iovs.05-1475
25. Jampol LM (1987) Oxygen therapy and intraocular oxygenation. Trans Am Ophthalmol Soc 85:407-437
26. Ben-Nun J, Alder VA, Cringle SJ, Constable IJ (1988) A new method for oxygen supply to acute ischemic retina. Invest Ophthalmol Vis Sci 29(2):298-304
27. Wilson CA, Benner JD, Berkowitz BA, Chapman CB, Peshock RM (1994) Transcorneal oxygenation of the preretinal vitreous. Arch Ophthalmol 112(6):839-845
28. Wilson CA, Berkowitz BA, Srebro R (1995) Perfluorinated organic liquid as an intraocular oxygen reservoir for the ischemic retina. Invest Ophthalmol Vis Sci 36(1):131-141
29. Cringle SJ, Yu DY, Alder VA, Su EN (1994) Intravitreal perfluorocarbon and oxygen delivery in induced retinal ischaemia. Adv Exp Med Biol 361:303-311
30. Sebag J (1987) Age-related changes in human vitreous structure. Graefes Arch Clin Exp Ophthalmol 225(2):89-93, doi: 10.1007/BF02160337
31. Sebag J (2004) Anomalous posterior vitreous detachment: A unifying concept in vitreo-retinal disease. Graefes Arch Clin Exp Ophthalmol 242(8):690-698, doi: 10.1007/s00417-004-0980-1
32. Gandorfer A (2008) Experimental evaluation of microplasmin - an alternative to vital dyes. Dev Ophthalmol 42:153-159, doi: 10.1159/ 000139004
33. Sebag J (2005) Molecular biology of pharmacologic vitreolysis. Trans Am Ophthalmol Soc 103:473-494
34. Sebag J (1987) Pharmacologic vitreolysis. Retina 18(1):1-3, doi: 10.1097/ 00006982-199818010-00001
35. Quiram PA, Leverenz VR, Baker RM, Dang L, Giblin FJ, Trese MT (2007) Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels. Retina 27(8):1090-1096
36. Laqua H (1980) [Rubeosis iridis following pars plana vitrectomy (author's transl)]. Klin Monatsbl Augenheilkd 177(1):24-30
37. Rice TA, Michels RG, Maguire MG, Rice EF (1983) The effect of lensectomy on the incidence of iris neovascularization and neovascular glaucoma after vitrectomy for diabetic retinopathy. Am J Ophthalmol 95(1):1-11
38. Alder VA, Cringle SJ, Brown M (1987) The effect of regional retinal photocoagulation on vitreal oxygen tension. Invest Ophthalmol Vis Sci 28(7):1078-1085
39. Budzynski E, Smith JH, Bryar P, Birol G, Linsenmeier RA (2008) Effects of photocoagulation on intraretinal PO2 in cat. Invest Ophthalmol Vis Sci 49(1):380-389, doi: 10.1167/iovs.07-0065
40. Diddie KR, Ernest JT (1977) The effect of photocoagulation on the choroidal vasculature and retinal oxygen tension. Am J Ophthalmol 84(1):62-66
41. Funatsu H, Wilson CA, Berkowitz BA, Sonkin PL (1997) A comparative study of the effects of argon and diode laser photocoagulation on retinal oxygenation. Graefes Arch Clin Exp Ophthalmol 235(3):168-175, doi: 10.1007/BF00941724
42. Landers MB 3rd, Stefansson E, Wolbarsht ML (1982) Panretinal photocoagulation and retinal oxygenation. Retina 2(3):167-175, doi: 10.1097/00006982-198200230-00007
43. Molnar I, Poitry S, Tsacopoulos M, Gilodi N, Leuenberger PM (1985) Effect of laser photocoagulation on oxygenation of the retina in miniature pigs. Invest Ophthalmol Vis Sci 26(10):1410-1414
44. Novack RL, Stefansson E, Hatchell DL (1990) The effect of photocoagulation on the oxygenation and ultrastructure of avascular retina. Exp Eye Res 50(3):289-296, doi: 10.1016/0014-4835(90)90213-E
45. Pournaras CJ, Ilic J, Gilodi N, Tsacopoulos M, Leuenberger MP (1985) Experimental venous thrombosis: Preretinal PO2 before and after photocoagulation. Klin Monatsbl Augenheilkd 186(6):500-501
46. Pournaras CJ, Tsacopoulos M, Strommer K, Gilodi N, Leuenberger PM (1990) Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology 97(10):1329-1333
47. Stefansson E (2006) Ocular oxygenation and the treatment of diabetic retinopathy. Surv Ophthalmol 51(4):364-380, doi: 10.1016/ j.survophthal.2006.04.005
48. Stefansson E, Hatchell DL, Fisher BL, Sutherland FS, Machemer R (1986) Panretinal photocoagulation and retinal oxygenation in normal and diabetic cats. Am J Ophthalmol 101(6):657-664
49. Stefansson E, Machemer R, de Juan E Jr, McCuen BW 2nd, Peterson J (1992) Retinal oxygenation and laser treatment in patients with diabetic retinopathy. Am J Ophthalmol 113(1):36-38
50. Yu DY, Cringle SJ, Su E, Yu PK, Humayun MS, Dorin G (2005) Laser-induced changes in intraretinal oxygen distribution in pigmented rabbits. Invest Ophthalmol Vis Sci 46(3):988-999, doi: 10.1167/iovs.04-0767
51. Blankenship GW, Machemer R (1985) Long-term diabetic vitrectomy results. Report of 10-year follow-up. Ophthalmology 92(4):503-506
52. Stefansson E, Novack RL, Hatchell DL (1990) Vitrectomy prevents retinal hypoxia in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 31(2):284-289
53. Nasrallah FP, Jalkh AE, Van Coppenolle F, Kado M, Trempe CL, McMeel JW et al (1988) The role of the vitreous in diabetic macular edema. Ophthalmology 95(10):1335-1339
54. Sivaprasad S, Ockrim Z, Massaoutis P, Ikeji F, Hykin PG, Gregor ZJ (2008) Posterior hyaloid changes following intravitreal triamcinolone and macular laser for diffuse diabetic macular Edema. Retina [epub ahead of print Jul 14]
55. Kaiser PK, Riemann CD, Sears JE, Lewis H (2001) Macular traction detachment and diabetic macular edema associated with posterior hyaloidal traction. Am J Ophthalmol 131(1):44-49, doi: 10.1016/ S0002-9394(00)00872-2
56. Lewis H (2001) The role of vitrectomy in the treatment of diabetic macularDedema. Am J Ophthalmol 131(1):123-125, doi: doi:10.1016/ S0002-9394(00)00660-7
57. Lewis H, Abrams GW, Blumenkranz MS, Campo RV (1992) Vitrectomy for diabetic macular traction and edema associated with posterior hyaloidal traction. Ophthalmology 99(5):753-759
58. Figueroa MS, Contreras I, Noval S (2008) Surgical and anatomical outcomes of pars plana vitrectomy for diffuse nontractional diabetic macular edema. Retina 28(3):420-426
59. Hartley KL, Smiddy WE, Flynn HW Jr, Murray TG (2008) Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina 28(3):410-419
60. Patel JI, Hykin PG, Schadt M, Luong V, Fitzke F, Gregor ZJ (2006) Pars plana vitrectomy for diabetic macular oedema: OCT and functional correlations. Eye 20(6):674-680, doi: 10.1038/sj.eye.6701945
61. Shimonagano Y, Makiuchi R, Miyazaki M, Doi N, Uemura A, Sakamoto T (2007) Results of visual acuity and foveal thickness in diabetic macular edema after vitrectomy. Jpn J Ophthalmol 51(3):204-209, doi: 10.1007/ s10384-007-0423-8
62. Stolba U, Binder S, Gruber D, Krebs I, Aggermann T, Neumaier B (2005) Vitrectomy for persistent diffuse diabetic macular edema. Am J Ophthalmol 140(2):295-301
63. Yamamoto T, Takeuchi S, Sato Y, Yamashita H (2007) Long-term follow-up results of pars plana vitrectomy for diabetic macular edema. Jpn J Ophthalmol 51(4):285-291, doi: 10.1007/s10384-007-0448-z
64. Yanyali A, Horozoglu F, Celik E, Nohutcu AF (2007) Long-term outcomes of pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema. Retina 27(5):557-566, doi: 10.1097/ 01.iae.0000249390.61854.d5
65. Hoerle S, Poestgens H, Schmidt J, Kroll P (2002) Effect of pars plana vitrectomy for proliferative diabetic vitreoretinopathy on preexisting diabetic maculopathy. Graefes Arch Clin Exp Ophthalmol 240(3):197-201, doi: 10.1007/s00417-002-0432-8
66. Terasaki H, Kojima T, Niwa H, Piao CH, Ueno S, Kondo M et al (2003) Changes in focal macular electroretinograms and foveal thickness after vitrectomy for diabetic macular edema. Invest Ophthalmol Vis Sci 44(10):4465-4472, doi: 10.1167/iovs.02-1313
67. Yamamoto S, Yamamoto T, Ogata K, Hoshino A, Sato E, Mizunoya S (2004) Morphological and functional changes of the macula after vitrectomy and creation of posterior vitreous detachment in eyes with diabetic macular edema. Doc Ophthalmol 109(3):249-253, doi: 10.1007/s10633-004-8056-4
68. Shah SP, Patel M, Thomas D, Aldington S, Laidlaw DA (2006) Factors predicting outcome of vitrectomy for diabetic macular oedema: Results of a prospective study. Br J Ophthalmol 90(1):33-36, doi: 10.1136/ bjo.2005.072934
69. Meyer CH (2007) Current treatment approaches in diabetic macular edema. Ophthalmologica 221(2):118-131, doi: 10.1159/000098257
70. Soliman W, Sander B, Soliman KA, Yehya S, Rahamn MS, Larsen M (2008) The predictive value of optical coherence tomography after grid laser photocoagulation for diffuse diabetic macular oedema. Acta Ophthalmol (Copenh) 86(3):284-291, doi: 10.1111/j.1600-0420.2007.01048.x
71. Arnarsson A, Stefansson E (2000) Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion. Invest Ophthalmol Vis Sci 41(3):877-879
72. Feke GT, Green GJ, Goger DG, McMeel JW (1982) Laser Doppler measurements of the effect of panretinal photocoagulation on retinal blood flow. Ophthalmology 89(7):757-762
73. Gottfredsdottir MS, Stefansson E, Jonasson F, Gislason I (1993) Retinal vasoconstriction after laser treatment for diabetic macular edema. Am J Ophthalmol 115(1):64-67
74. Wilson CA, Stefansson E, Klombers L, Hubbard LD, Kaufman SC, Ferris FL 3rd (1988) Optic disk neovascularization and retinal vessel diameter in diabetic retinopathy. Am J Ophthalmol 106(2):131-134
75. Hikichi T, Yoshida A, Konno S, Trempe CL (1996) Role of the vitreous in central retinal vein occlusion. Nippon Ganka Gakkai Zasshi 100(1):63-68
76. Takahashi MK, Hikichi T, Akiba J, Yoshida A, Trempe CL (1997) Role of the vitreous and macular edema in branch retinal vein occlusion. Ophthalmic Surg Lasers 28(4):294-299
77. Charbonnel J, Glacet-Bernard A, Korobelnik JF, Nyouma-Moune E, Pournaras CJ, Colin J et al (2004) Management of branch retinal vein occlusion with vitrectomy and arteriovenous adventitial sheathotomy, the possible role of surgical posterior vitreous detachment. Graefes Arch Clin Exp Ophthalmol 242(3):223-228, doi: 10.1007/s00417-003-0824-4
78. Kumagai K, Furukawa M, Ogino N, Uemura A, Larson E (2007) Long-term outcomes of vitrectomy with or without arteriovenous sheathotomy in branch retinal vein occlusion. Retina 27(1):49-54, doi: 10.1097/ 01.iae.0000221996.77421.69
79. Hvarfner C, Larsson J (2006) Vitrectomy for non-ischaemic macular oedema in retinal vein occlusion. Acta Ophthalmol Scand 84(6):812-814, doi: 10.1111/j.1600-0420.2006.00749.x
80. Newton I (1726) Philosophiæ naturalis principia mathematica. Editio tertia aucta et emendata. Regia Societas, London, p 14
81. Newton I (1999) The Principia: Mathematical Principles of Natural Philosophy. A new Translation by I. Bernard Cohen and Anne Whitman. University of California Press, Berkely, p 417
82. Pocock G, Richards CD (2004) Human physiology. The basis of medicine, 2nd edn ed. Oxford University Press Inc., New York
83. Cunha-Vaz J (1979) The blood-ocular barriers. Surv Ophthalmol 23(5):279-296, doi: 10.1016/0039-6257(79)90158-9
84. Cunha-Vaz JG, Travassos A (1984) Breakdown of the blood-retinal barriers and cystoid macular edema. Surv Ophthalmol 28(Suppl):485-492, doi: 10.1016/0039-6257(84)90230-3
85. Bringmann A, Uckermann O, Pannicke T, Iandiev I, Reichenbach A, Wiedemann P (2005) Neuronal versus glial cell swelling in the ischaemic retina. Acta Ophthalmol Scand 83(5):528-538, doi: 10.1111/ j.1600-0420.2005.00565.x
86. Massin P, Girach A, Erginay A, Gaudric A (2006) Optical coherence tomography: A key to the future management of patients with diabetic macular oedema. Acta Ophthalmol Scand 84(4):466-474, doi: 10.1111/ j.1600-0420.2006.00694.x
87. Stefansson E, Wilson CA, Lightman SL, Kuwabara T, Palestine AG, Wagner HG (1987) Quantitative measurements of retinal edema by specific gravity determinations. Invest Ophthalmol Vis Sci 28(8):1281-1289
88. Knudsen LL (2007) Identification of diabetic macular oedema using retinal thickness measurements. Acta Ophthalmol Scand 85(1):27-31, doi: 10.1111/j.1600-0420.2006.00783.x
89. Neubauer AS, Chryssafis C, Priglinger SG, Haritoglou C, Thiel M, Welge-Lussen U et al (2007) Topography of diabetic macular oedema compared with fluorescein angiography. Acta Ophthalmol Scand 85(1):32-39, doi: 10.1111/j.1600-0420.2006.00727.x
90. Soliman W, Sander B, Jorgensen TM (2007) Enhanced optical coherence patterns of diabetic macular oedema and their correlation with the pathophysiology. Acta Ophthalmol Scand 85(6):613-617, doi: 10.1111/ j.1600-0420.2007.00917.x
91. Klein R, Klein BE, Moss SE, Cruickshanks KJ (1995) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 102(1):7-16
92. Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW (1999) Diabetic macular edema: Risk factors and concomitants. Acta Ophthalmol Scand 77(2):170-175, doi: 10.1034/j.1600-0420.1999.770211.x
93. Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM (2004) Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69. Arch Ophthalmol 122(11):1631-1640, doi: 10.1001/archopht.122.11.1631
94. Higgins GT, Khan J, Pearce IA (2007) Glycaemic control and control of risk factors in diabetes patients in an ophthalmology clinic: What lessons have we learned from the UKPDS and DCCT studies. Acta Ophthalmol Scand 85(7):772-776, doi: 10.1111/j.1600-0420.2007.00944.x
95. Stefansson E (2001) The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmol Scand 79(5):435-440, doi: 10.1034/j.1600-0420.2001.790502.x
96. Kristinsson JK, Gottfredsdottir MS, Stefansson E (1997) Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol 81(4):274-278
97. Stefansson E, Landers MB 3rd, Wolbarsht ML (1983) Oxygenation and vasodilatation in relation to diabetic and other proliferative retinopathies. Ophthalmic Surg 14(3):209-226
98. Kokame GT, de Leon MD, Tanji T (2001) Serous retinal detachment and cystoid macular edema in hypotony maculopathy. Am J Ophthalmol 131(3):384-386, doi: 10.1016/S0002-9394(00)00794-7
99. Schubert HD (1996) Postsurgical hypotony: Relationship to fistulization, inflammation, chorioretinal lesions, and the vitreous. Surv Ophthalmol 41(2):97-125, doi: 10.1016/S0039-6257(96)80001-4
100. Stefansson E (2007) Ocular hypotony: What is the mechanism of effusion and oedema? Acta Ophthalmol Scand 85(6):584-585, doi: 10.1111/ j.1600-0420.2007.01032.x
101. Funatsu H, Yamashita H, Nakamura S, Mimura T, Eguchi S, Noma H et al (2006) Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 113(2):294-301, doi: 10.1016/j.ophtha.2005.10.030
102. Patel JI, Tombran-Tink J, Hykin PG, Gregor ZJ, Cree IA (2006) Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles. Exp Eye Res 82(5):798-806, doi: 10.1016/j.exer.2005.10.002
103. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE (2002) Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care 25(12):2328-2334, doi: 10.2337/diacare.25.12.2328
104. Cunha-Vaz JG (1985) Vitreous fluorophotometry recordings in posterior segment disease. Graefes Arch Clin Exp Ophthalmol 222(4-5):241-247, doi: 10.1007/BF02133688
105. Krogsaa B, Lund-Andersen H, Mehlsen J, Sestoft L (1987) Blood-retinal barrier permeability versus diabetes duration and retinal morphology in insulin dependent diabetic patients. Acta Ophthalmol (Copenh) 65(6):686-692
106. Phillips RP, Ross PG, Sharp PF, Forrester JV (1990) Use of temporal information to quantify vascular leakage in fluorescein angiography of the retina. Clin Phys Physiol Meas 11(Suppl A):81-85
107. Ring K, Larsen M, Dalgaard P, Andersen HL (1987) Fluorophotometric evaluation of ocular barriers and of the vitreous body in the aphakic eye. Acta Ophthalmol Suppl 182:160-162
108. Sander B, Larsen M, Moldow B, Lund-Andersen H (2001) Diabetic macular edema: Passive and active transport of fluorescein through the blood-retina barrier. Invest Ophthalmol Vis Sci 42(2):433-438
109. Smith RT, Lee CM, Charles HC, Farber M, Cunha-Vaz JG (1987) Quantification of diabetic macular edema. Arch Ophthalmol 105(2):218-222
110. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE et al (2001) UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44(2):156-163, doi: 10.1007/s001250051594
111. Averous K, Erginay A, Timsit J, Haouchine B, Gaudric A, Massin P (2006) Resolution of diabetic macular oedema following high altitude exercise. Acta Ophthalmol Scand 84(6):830-831, doi: 10.1111/ j.1600-0420.2006.00701.x
112. Nguyen QD, Shah SM, Van Anden E, Sung JU, Vitale S, Campochiaro PA (2004) Supplemental oxygen improves diabetic macular edema: A pilot study. Invest Ophthalmol Vis Sci 45(2):617-624, doi: 10.1167/iovs.03-0557
113. Kiryu J, Ogura Y (1996) Hyperbaric oxygen treatment for macular edema in retinal vein occlusion: Relation to severity of retinal leakage. Ophthalmologica 210(3):168-170
114. Roy M, Bartow W, Ambrus J, Fauci A, Collier B, Titus J (1989) Retinal leakage in retinal vein occlusion: Reduction after hyperbaric oxygen. Ophthalmologica 198(2):78-83
115. Jacobi KW, Kluge K (1972) Measuring of oxygen partial pressure before the retina following photocoagulation]. Ber Zusammenkunft Dtsch Ophthalmol Ges 71:397-401
116. Maeda N, Tano Y, Ikeda T, Imai T, Hamano H, Manabe R (1992) [Vitreous oxygen tension of proliferative diabetic retinopathy]. Nippon Ganka Gakkai Zasshi 96(4):511-515
117. Soliman W, Vinten M, Sander B, Soliman KA, Yehya S, Rahman MS et al (2008) Optical coherence tomography and vessel diameter changes after intravitreal bevacizumab in diabetic macular oedema. Acta Ophthalmol (Copenh) 86(4):365-371, doi: 10.1111/j.1600-0420.2007.01057.x
118. Vinten M, Larsen M, Lund-Andersen H, Sander B, La Cour M (2007) Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema. Acta Ophthalmol Scand 85(1):21-26, doi: 10.1111/j.1600-0420.2006.00806.x
119. Christoffersen N, Larsen M (2004) Unilateral diabetic macular oedema secondary to central retinal vein congestion. Acta Ophthalmol Scand 82(5):591-595, doi: 10.1111/j.1600-0420.2004.00326.x
120. Kylstra JA, Wierzbicki T, Wolbarsht ML, Landers MB 3rd, Stefansson E (1986) The relationship between retinal vessel tortuosity, diameter, and transmural pressure. Graefes Arch Clin Exp Ophthalmol 224(5):477-480, doi: 10.1007/BF02173368
121. Larsen M (2005) Unilateral macular oedema secondary to retinal venous congestion without occlusion in patients with diabetes mellitus. Acta Ophthalmol Scand 83(4):428-435, doi: 10.1111/j.1395-3907.2005.00478.x
122. Sohn JH, Song SJ (2006) Arteriovenous sheathotomy for persistent macular edema in branch retinal vein occlusion. Korean J Ophthalmol 20(4):210-214
123. Wrigstad A, Algvere P (2006) Arteriovenous adventitial sheathotomy for branch retinal vein occlusion: Report of a case with longterm follow-up. Acta Ophthalmol Scand 84(5):699-702, doi: 10.1111/ j.1600-0420.2006.00697.x
124. Crafoord S, Karlsson N, la Cour M (2008) Sheathotomy in complicated cases of branch retinal vein occlusion. Acta Ophthalmol (Copenh) 86(2):146-150, doi: 10.1111/j.1600-0420.2007.00998.x
125. Mandelcorn MS, Mandelcorn E, Guan K, Adatia FA (2007) Surgical macular decompression for macular edema in retinal vein occlusion. Can J Ophthalmol 42(1):116-122, doi: 10.3129/can j ophthalmol.06-091
126. Shimura M, Nakazawa T, Yasuda K, Kunikata H, Shiono T, Nishida K (2008) Visual prognosis and vitreous cytokine levels after arteriovenous sheathotomy in branch retinal vein occlusion associated with macular oedema. Acta Ophthalmol (Copenh) 86(4):377-384, doi: 10.1111/ j.1600-0420.2007.01074.x
127. Karasheva G, Goebel W, Klink T, Haigis W, Grehn F (2003) Changes in macular thickness and depth of anterior chamber in patients after filtration surgery. Graefes Arch Clin Exp Ophthalmol 241(3):170-175, doi: 10.1007/s00417-003-0628-6
128. Iturralde D, Spaide RF, Meyerle CB, Klancnik JM, Yannuzzi LA, Fisher YL et al (2006) Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study. Retina 26(3):279-284, doi: 10.1097/00006982-200603000-00005
129. Mason JO 3rd, Albert MA Jr, Vail R (2006) Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina 26(3):356-357, doi: 10.1097/00006982-200603000-00018
130. Audren F, Erginay A, Haouchine B, Benosman R, Conrath J, Bergmann JF et al (2006) Intravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trial. Acta Ophthalmol Scand 84(5):624-630, doi: 10.1111/j.1600-0420.2006.00700.x
131. Edelman JL, Lutz D, Castro MR (2005) Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown. Exp Eye Res 80(2):249-258, doi: 10.1016/ j.exer.2004.09.013
132. Jonas JB (2005) Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Acta Ophthalmol Scand 83(6):645-663, doi: 10.1111/j.1600-0420.2005.00592.x
133. Sorensen TL, Haamann P, Villumsen J, Larsen M (2005) Intravitreal triamcinolone for macular oedema: Efficacy in relation to aetiology. Acta Ophthalmol Scand 83(1):67-70, doi: 10.1111/j.1600-0420.2004.00336.x
134. Margolis R, Singh RP, Bhatnagar P, Kaiser PK (2008) Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema. Acta Ophthalmol (Copenh) 86(1):105-110
135. Sivaprasad S, McCluskey P, Lightman S (2006) Intravitreal steroids in the management of macular oedema. Acta Ophthalmol Scand 84(6):722-733, doi: 10.1111/j.1600-0420.2006.00698.x
136. Wang L, Song H (2008) Effects of repeated injection of intravitreal triamcinolone on macular oedema in central retinal vein occlusion. Acta Ophthalmol [Epub ahead of print May 27]
137. Vinores SA, Xiao WH, Aslam S, Shen J, Oshima Y, Nambu H et al (2006) Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol 206(3):749-758, doi: 10.1002/jcp.20525
138. Krebs I, Brannath W, Glittenberg C, Zeiler F, Sebag J, Binder S (2007) Posterior vitreomacular adhesion: A potential risk factor for exudative age-related macular degeneration. Am J Ophthalmol 144(5):741-746, doi: 10.1016/j.ajo.2007.07.024
139. Weber-Krause B, Eckardt U (1996) Incidence of posterior vitreous detachment in eyes with and without age-related macular degeneration. An ultrasonic study. Ophthalmologe 93(6):660-665, doi: 10.1007/s003470050054
140. Ondes F, Yilmaz G, Acar MA, Unlu N, Kocaoglan H, Arsan AK (2000) Role of the vitreous in age-related macular degeneration. Jpn J Ophthalmol 44(1):91-93, doi: 10.1016/S0021-5155(99)00174-4
141. Hayreh SS, Jonas JB (2004) Posterior vitreous detachment: Clinical correlations. Ophthalmologica 218(5):333-343, doi: 10.1159/000079476
142. Lambert HM, Capone A Jr, Aaberg TM, Sternberg P Jr, Mandell BA, Lopez PF (1992) Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 113(3):257-262
143. Schmidt JC, Mennel S, Horle S, Meyer CH (2006) High incidence of vitreomacular traction in recurrent choroidal neovascularisation after repeated photodynamic therapy. Br J Ophthalmol 90(11):1361-1362, doi: 10.1136/bjo.2006.094201 doi:
144. Meyer CH, Toth CA (2001) Retinal pigment epithelial tear with vitreomacular attachment: A novel pathogenic feature. Graefes Arch Clin Exp Ophthalmol 239(5):325-333, doi: 10.1007/s004170100259
145. Gross-Jendroska M, Flaxel CJ, Schwartz SD, Holz FG, Fitzke FW, Gabel VP et al (1998) Treatment of pigment epithelial detachments due to age-related macular degeneration with intra-ocular C3F8 injection. Aust N Z J Ophthalmol 26(4):311-317, doi: 10.1111/j.1442-9071.1998.tb01335.x
146. Liang J, Zheng L, Yi C, Barbazetto I, Dillon J (2002) Affection on oxygen tension of the lens after vitrectomy. Yan Ke Xue Bao 18(2):67-70
147. Holekamp NM, Shui YB, Beebe D (2006) Lower intraocular oxygen tension in diabetic patients: Possible contribution to decreased incidence of nuclear sclerotic cataract. Am J Ophthalmol 141(6):1027-1032, doi: 10.1016/j.ajo.2006.01.016
148. Chauvaud D, Clay-Fressinet C, Pouliquen Y, Offret G (1976) Opacification of the crystalline lens after trabeculectomy. Study of 95 cases. Arch Ophtalmol (Paris) 36(5):379-386
149. Daugeliene L, Yamamoto T, Kitazawa Y (2000) Cataract development after trabeculectomy with mitomycin C: A 1-year study. Jpn J Ophthalmol 44(1):52-57, doi: 10.1016/S0021-5155(99)00145-8
150. Popovic V, Sjostrand J (1991) Long-term outcome following trabeculectomy: I Retrospective analysis of intraocular pressure regulation and cataract formation. Acta Ophthalmol (Copenh) 69(3):299-304
151. Quigley HA, Buhrmann RR, West SK, Isseme I, Scudder M, Oliva MS (2000) Long term results of glaucoma surgery among participants in an east African population survey. Br J Ophthalmol 84(8):860-864, doi: 10.1136/ bjo.84.8.860
152. Razzak A, al Samarrai A, Sunba MS (1991) Incidence of posttrabeculectomy cataract among Arabs in Kuwait. Ophthalmic Res 23(1):21-23
153. Sihota R, Gupta V, Agarwal HC (2004) Long-term evaluation of trabeculectomy in primary open angle glaucoma and chronic primary angle closure glaucoma in an Asian population. Clin Experiment Ophthalmol 32(1):23-28, doi: 10.1046/j.1442-9071.2004.00752.x
154. Vesti E (1993) Development of cataract after trabeculectomy. Acta Ophthalmol (Copenh) 71(6):777-781
155. Chang S (2006) LXII Edward Jackson lecture: Open angle glaucoma after vitrectomy. Am J Ophthalmol 141(6):1033-1043, doi: 10.1016/ j.ajo.2006.02.014
156. Helbig H, Noske W, Kellner U, Foerster MH (1995) Oxygen in the anterior chamber before and after cataract operation. Ophthalmologe 92(3):325-328
157. Helbig H, Schlotzer-Schrehardt U, Noske W, Kellner U, Foerster MH, Naumann GO (1994) Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol 3(3):148-153
158. Sakaue H, Tsukahara Y, Negi A, Ogino N, Honda Y (1989) Measurement of vitreous oxygen tension in human eyes. Jpn J Ophthalmol 33(2):199-203
159. Wilson CA, Berkowitz BA, McCuen BW 2nd, Charles HC (1992) Measurement of preretinal oxygen tension in the vitrectomized human eye using fluorine-19 magnetic resonance spectroscopy. Arch Ophthalmol 110(8):1098-1100